Trastuzumab in Female Breast Cancer Patients With Reduced Left Ventricular Ejection Fraction

BACKGROUND: Trastuzumab is life‐extending therapy for breast cancer patients overexpressing the human epidermal growth factor receptor 2 (HER2+), but has known cardiotoxic risk. We sought to determine if trastuzumab can be administered to patients with reduced baseline cardiac function at no higher...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Heart Assoc
Main Authors: Nowsheen, Somaira, Aziz, Khaled, Park, Jae Yoon, Lerman, Amir, Villarraga, Hector R., Ruddy, Kathryn Jean, Herrmann, Joerg
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201446/
https://ncbi.nlm.nih.gov/pubmed/30371238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008637
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker